Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Avanos Medical (NYSE: AVNS) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. Michael Greiner, the company's interim chief executive officer, will deliver a presentation on Monday, January 13, at approximately 3:45 p.m. PST.
The presentation will be accessible via webcast through the Investors section of the Avanos Medical website, where it will also be archived for future reference.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, AVNS gained 0.58%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.
About Avanos Medical, Inc. Avanos Medical, Inc. (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302343007.html
SOURCE Avanos Medical, Inc.